Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Idiopathic Pulmonary Fibrosis
|
63 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Immune System Diseases
|
116 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||
Multiple Sclerosis
|
1022 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Primary biliary cirrhosis
|
667 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.810 | 1.000 | 3 | 2012 | 2014 | |||||
Aplastic Anemia
|
30 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2012 | 2018 | |||||
Arthritis
|
69 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Biliary cirrhosis
|
36 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Drug-Induced Liver Disease
|
29 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Liver carcinoma
|
942 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.900 | 0.909 | 11 | 2013 | 2019 | |||||
Complete atrioventricular block
|
96 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.060 | 1.000 | 6 | 2013 | 2019 | |||||
Hepatitis B Virus-Related Hepatocellular Carcinoma
|
8 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Hepatitis C
|
347 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2013 | 2013 | |||||
Juvenile arthritis
|
128 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 0.500 | 2 | 2013 | 2015 | |||||
Juvenile rheumatoid arthritis
|
10 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 0.500 | 2 | 2013 | 2015 | |||||
Pulmonary Fibrosis
|
25 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Ankylosing spondylitis
|
609 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2013 | 2013 | ||||||
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
|
3 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Encephalitis, St. Louis
|
34 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Liver Cirrhosis
|
189 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2013 | 2013 | ||||||
Graves Disease
|
352 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||
Adult type dermatomyositis
|
31 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Dermatomyositis
|
34 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Hepatitis B
|
519 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.050 | 1.000 | 5 | 2015 | 2020 | |||||
Hepatitis B, Chronic
|
84 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.030 | 1.000 | 3 | 2015 | 2019 | |||||
Autoimmune Chronic Hepatitis
|
23 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2017 | 2017 |